Graziano Seghezzi
InvestorManaging Partner at Sofinnova Partners · Board director at Hookipa Pharma
Paris, France
Writes $100K – $5M checks · typically $1.5M
About
Managing Partner at Sofinnova Partners since 2006 and part of the Sofinnova Capital Strategy team, focused on biotech company creation. He has led numerous exits (including Mablink, Corvidia, GlycoVaxyn, and Omthera) and drove the firm's expansion in Italy, founding the BiovelocITA accelerator and the Sofinnova Telethon Fund. He began his VC career at Sofinnova in 2001, worked at Index Ventures (2003-2006), and previously did academic oncology and cardiovascular research at NYU School of Medicine.
Contact· published on Graziano's own website
Invests in
Biotech
Board director at Hookipa Pharma
Intro paths
In turn, Graziano can intro founders to Hookipa Pharma's investors below.
Hookipa Pharma's investors · 2
Experience
- Sofinnova PartnersManaging Partnercurrent2017 — present
- Sofinnova PartnersPartner2006 — 2017
- Index VenturesPrincipal2003 — 2006
- Sofinnova PartnersVenture Consultant2002 — 2003Paris, Île-de-France, France
- NYU Langone Medical CenterPostdoc1996 — 2000
Skills & more
Languages English · French · Italian
From Graziano's professional profile.
Deals · 1
Hookipa PharmaBoard seat
via Sofinnova Partners · filed Feb 2019
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
Corvidia TherapeuticsEntheraGlycoEraHotSpot TherapeuticsMission TherapeuticsT-Therapeutics
Investor
Corvidia TherapeuticsGlycovaxynMablinkOmthera Pharmaceuticals
Sources: SEC Form D filings · the firm's website.
Colleagues at Sofinnova Partners
Frequently asked questions
- Who is Graziano Seghezzi?
- Managing Partner at Sofinnova Partners since 2006 and part of the Sofinnova Capital Strategy team, focused on biotech company creation. He has led numerous exits (including Mablink, Corvidia, GlycoVaxyn, and Omthera) and drove the firm's expansion in Italy, founding the BiovelocITA accelerator and the Sofinnova Telethon Fund. He began his VC career at Sofinnova in 2001, worked at Index Ventures (2003-2006), and previously did academic oncology and cardiovascular research at NYU School of Medicine.
- Where does Graziano Seghezzi work?
- Graziano Seghezzi is Managing Partner at Sofinnova Partners and Board director at Hookipa Pharma.
- What does Graziano Seghezzi invest in?
- Graziano Seghezzi invests in Biotech.
- What check size does Graziano Seghezzi write?
- Graziano Seghezzi typically writes checks of $100K – $5M.
- What boards does Graziano Seghezzi sit on?
- Graziano Seghezzi holds tracked board seats at Corvidia Therapeutics, Enthera, GlycoEra, Hookipa Pharma, HotSpot Therapeutics, Mission Therapeutics, T-Therapeutics.
- What companies has Graziano Seghezzi invested in?
- Investments tracked here include Corvidia Therapeutics, Glycovaxyn, Mablink, Omthera Pharmaceuticals.
- Where did Graziano Seghezzi go to school?
- Graziano Seghezzi studied at Rotterdam School of Management, Erasmus University (Master of Business Administration (MBA), Entrepreneurship/Entrepreneurial Studies); Università di Pavia (Biological Sciences, Genetics and Microbiology).
Same school
Also attended Rotterdam School of Management, Erasmus University228
+ 222 more
Shared employers
Also worked at Sofinnova Partners76
+ 70 more
Also worked at Index Ventures121
+ 115 more
Also worked at NYU Langone Medical Center34
+ 28 more